NASDAQ: IMUX
Immunic Inc Earnings Dates, Reports, Calls

Immunic earnings were -$100.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest IMUX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$25.2M, up 3.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IMUX reported annual earnings of -$100.5M, with 7.4% growth. The next IMUX earnings date is Jun 11, 2025.

IMUX earnings history

Current Revenue
$0.0
Current Earnings
-$100.5M
Current Profit Margin
0%

IMUX Return on Equity

Current Company
-194.4%
Current Industry
-2%
Current Market
34.1%
IMUX's Return on Equity (-194.4%)... subscribe to Premium to read more.
High Return on Equity Performance

IMUX undefined

Current Company
-135.7%
Current Industry
-0.4%
IMUX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IMUX announces earnings.

IMUX undefined

Current Company
-537.67%
Current Industry
5.9%
IMUX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IMUX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IMUX-$100.37M-$100.51MN/A-$1.00
COYA-$15.57M-$14.88MN/A-$0.98
CCCC-$96.95M-$105.32MN/A-$1.52
ORMP-$14.83M-$19.06MN/A-$0.48
ANIX-$12.45M-$12.48MN/A-$0.39

IMUX earnings dates

Next earnings date
Jun 11, 2025

Immunic Earnings Reports & History FAQ

What were Immunic's earnings last quarter?

Immunic (NASDAQ: IMUX) reported Q4 2024 earnings per share (EPS) of -$0.25, up 84.38% year over year. Total IMUX earnings for the quarter were -$25.18 million. In the same quarter last year, Immunic's earnings per share (EPS) was -$1.60.

If you're new to stock investing, here's how to buy Immunic stock.

When does Immunic report earnings?

The next IMUX earnings call is Invalid Date. Add IMUX to your watchlist to be reminded of Immunic's next earnings date.

What was IMUX's earnings growth in the past year?

As of Immunic's earnings date in Q2 2025, Immunic's earnings has grown year over year. IMUX earnings in the past year totalled -$100.51 million.

Is Immunic profitable or losing money?

As of the last Immunic earnings report, Immunic is currently losing money. Immunic's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$100.51 million, a 7.37% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.